This inventor holds 3 USPTO granted patents, plus 2 CIPO patents. Top assignee: Bayer Corporation. Active years: 1998-2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998-2001
Title: Innovations by Koleen K Messenger
Introduction
Koleen K Messenger is an accomplished inventor based in Granger, IN (US). With a focus on improving analytical methods in fluid testing, he has made significant contributions to the field. His work has led to the development of innovative techniques that enhance the accuracy of test results.
Latest Patents
Koleen holds 3 patents, showcasing his expertise and dedication to innovation. His latest patents include a method for improving the accuracy of the semi-quantitative determination of analyte in fluid samples. This method enhances the determination of the concentration of a first analyte based on the presence of a second analyte, ultimately increasing accuracy and reducing false results. Another notable patent is an assay for the detection of creatinine, which involves a unique reagent formulation that stabilizes the detection process through the addition of an ionizable phosphate compound.
Career Highlights
Koleen K Messenger is currently employed at Bayer Corporation, where he continues to apply his innovative thinking to real-world challenges. His work at Bayer has allowed him to collaborate with other talented professionals in the field, further advancing the company's research and development efforts.
Collaborations
Koleen has worked alongside notable colleagues such as Michael J Pugia and Carol A Miller. Their combined expertise has contributed to the success of various projects and innovations within the company.
Conclusion
Koleen K Messenger's contributions to the field of fluid testing and analysis are noteworthy. His innovative patents and collaborative efforts at Bayer Corporation highlight his commitment to advancing technology in healthcare. His work continues to impact the accuracy of diagnostic methods, benefiting both the industry and patients alike.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
